1WHO. Guidelines for the programmatic management of drug-resistant tuberculosis : Emergency update 2008. Geneva, Switzerland: WHO, 2008.
2Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin Infect Dis, 1997, 24 Suppl: $121-130.
5Wright A, Zignol M, Van Deun A, et al. Epidemiology of antituberculosis drug resistance 2002-07:an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet, 2009, 373: 1861-1873.
4WHO. Guidelines for the programmatic management of drug- resistant tuberculosis: emergency update 2005[R]. Geneva, Swit- zerland: WHO, 2008: 15.
5WHO. Multidrug and extensively drag-resistant TB (M/XDR- TB): 2010 global report on surveillance and response[R]. Gen- eva: WHO, 2010: 25.
6Chan ED,Reves R,Belisle.IT. Diagnosis of tuberculosis by a visually detectable immunoassay for lipoarabinomannan[J].{H}American Journal of Respiratory and Critical Care Medicine,2000,(05).
7Perkins MD,Conde MB,Martins. Serologic diagnosis of tuberculosis using a simple commercial multiantigen assay[J].{H}CHEST,2003,(01):107-112.
8Okuda Y,Maekura R,Hirotani A. Rapid serodiagnosis of active pulmonary Mycobacterium tuberculosis by analysis of results from multiple antigen-specific tests[J].{H}Journal of Clinical Microbiology,2004,(03):1136-1141.
9Fischetti VA,Nelson D,Schuch R. Reinventing phage therapy:are the parts greater than the sun[J].{H}Nature Biotechnology,2006,(12):1508-1511.
